<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>GP Quick‑Glance Guide • Urological Red Flags & First‑Line Actions</title>
  <meta name="description" content="Clean, modern, light‑theme reference for GPs: bladder, renal, testicular cancer red flags and primary‑care actions." />
  <style>
    /* ================
       Design Tokens
       ================ */
    :root{
      --bg: #f7f9fc;
      --surface: #ffffff;
      --ink: #1e293b;           /* slate-800 */
      --muted: #5b677a;         /* slate-600 */
      --border: #e7ecf3;        /* light border */
      --brand: #3b82f6;         /* blue-500 */
      --brand-ink: #0b3d91;
      --good: #16a34a;          /* green-600 */
      --warn: #f59e0b;          /* amber-500 */
      --info: #06b6d4;          /* cyan-500 */
      --bad: #dc2626;           /* red-600 */
      --card-shadow: 0 10px 24px rgba(31, 41, 55, 0.08), 0 1px 3px rgba(31, 41, 55, 0.06);
      --radius-xl: 18px;
      --radius-lg: 14px;
      --radius-md: 10px;
      --radius-sm: 8px;
      --space: clamp(12px, 1.8vmin, 18px);
      --space-lg: clamp(16px, 2.2vmin, 24px);
      --space-xl: clamp(22px, 4vmin, 48px);
      --maxw: 1200px;
    }

    *{box-sizing:border-box}
    html, body{height:100%}
    body{
      margin:0; font-family: ui-sans-serif, system-ui, -apple-system, Segoe UI, Roboto, Helvetica, Arial, "Apple Color Emoji", "Segoe UI Emoji";
      background: var(--bg); color: var(--ink);
    }

    /* Layout */
    .shell{max-width: var(--maxw); margin: 0 auto; padding: 0 var(--space-lg);} 
    header.hero{
      background: linear-gradient(180deg, #ffffff, #f5f8ff);
      border-bottom: 1px solid var(--border);
    }
    .hero-inner{display:grid; grid-template-columns: 1.2fr .8fr; gap: var(--space-xl); align-items:center; padding: var(--space-xl) 0;}
    @media (max-width: 900px){ .hero-inner{grid-template-columns: 1fr;} }

    .brand-chip{
      display:inline-flex; align-items:center; gap:8px; 
      background:#e8f0ff; color: var(--brand-ink); border:1px solid #d7e6ff; padding:6px 10px; border-radius:999px; font-weight:600; font-size:14px;
    }
    .brand-chip svg{width:18px; height:18px}

    h1{font-size: clamp(28px, 3.6vw, 44px); line-height:1.1; margin: 14px 0 10px;}
    .subtitle{color: var(--muted); font-size: clamp(15px, 1.6vw, 18px)}

    .cta-row{display:flex; gap:12px; flex-wrap: wrap; margin-top: 20px}
    .btn{appearance:none; border:none; border-radius: 999px; padding:12px 18px; font-weight:700; cursor:pointer; transition: .2s transform ease, .2s box-shadow ease, .2s background ease;}
    .btn-primary{background: var(--brand); color:white; box-shadow: 0 8px 18px rgba(59,130,246,.25)}
    .btn-primary:hover{transform: translateY(-1px); box-shadow: 0 12px 24px rgba(59,130,246,.28)}
    .btn-ghost{background: #eef2ff; color:#4338ca; border:1px solid #e0e7ff}

    .hero-card{
      background: var(--surface); border: 1px solid var(--border); border-radius: var(--radius-xl); padding: var(--space-lg);
      box-shadow: var(--card-shadow);
    }

    /* TOC */
    .toc{
      position: sticky; top: 16px; align-self: start; background: var(--surface);
      border:1px solid var(--border); border-radius: var(--radius-lg); box-shadow: var(--card-shadow);
      padding: var(--space-lg);
    }
    .toc h3{margin:0 0 8px; font-size: 16px}
    .toc a{display:block; padding:8px 10px; border-radius: 8px; text-decoration:none; color: var(--muted); font-weight:600; border:1px solid transparent}
    .toc a:hover{background:#f1f5ff; color:#1e3a8a; border-color:#e0e7ff}

    /* Content */
    main{padding: var(--space-xl) 0}
    .grid{display:grid; grid-template-columns: 1fr 320px; gap: var(--space-xl)}
    @media (max-width: 1100px){ .grid{grid-template-columns:1fr} }

    section.card{
      background: var(--surface); border:1px solid var(--border); border-radius: var(--radius-xl);
      padding: clamp(18px, 2.2vmin, 26px); margin-bottom: var(--space-xl); box-shadow: var(--card-shadow);
    }
    section.card h2{margin-top:0; font-size: clamp(22px, 2.8vw, 28px)}
    section.card h3{margin-top: 18px; font-size: clamp(18px, 2.2vw, 22px)}
    p{color: var(--ink); opacity:.9}

    .pill{display:inline-flex; gap:8px; align-items:center; padding:6px 10px; border-radius:999px; font-weight:700; font-size:12px; letter-spacing:.02em; border:1px solid transparent}
    .pill.red{background:#fee2e2; color:#7f1d1d; border-color:#fecaca}
    .pill.green{background:#dcfce7; color:#14532d; border-color:#bbf7d0}
    .pill.blue{background:#dbeafe; color:#1e3a8a; border-color:#bfdbfe}
    .pill.amber{background:#fef3c7; color:#7c2d12; border-color:#fde68a}

    .badge{display:inline-block; font-weight:700; font-size:11px; padding:4px 8px; border-radius:6px; border:1px solid var(--border); background:#f8fafc; color:#0f172a}

    .kpi{display:grid; grid-template-columns: repeat(3, 1fr); gap:14px; margin-top:12px}
    .kpi .tile{background:#f8fafc; border:1px solid var(--border); border-radius:12px; padding:12px 14px}
    .kpi .num{font-size:22px; font-weight:800}
    .kpi .lbl{color:var(--muted); font-size:12px}
    @media (max-width: 600px){ .kpi{grid-template-columns:1fr} }

    /* Lists */
    ul{padding-left: 22px}
    .list-tight li{margin-bottom: 6px}

    /* Callouts */
    .callout{display:flex; gap:12px; align-items:flex-start; padding:14px; border-radius: var(--radius-md); border:1px solid; margin: 12px 0}
    .callout svg{width:22px; height:22px; flex: 0 0 auto;}
    .callout.red{background:#fff1f2; border-color:#fecdd3; color:#7f1d1d}
    .callout.green{background:#ecfdf5; border-color:#a7f3d0; color:#064e3b}
    .callout.blue{background:#eff6ff; border-color:#bfdbfe; color:#1e3a8a}
    .callout.amber{background:#fffbeb; border-color:#fde68a; color:#7c2d12}

    /* Flow cards */
    .flow{display:grid; grid-template-columns:repeat(3, minmax(0,1fr)); gap:14px}
    .step{background:#f8fafc; border:1px solid var(--border); border-radius:12px; padding:14px}
    .step .title{font-weight:800; margin-bottom:6px}
    .step .hint{color:var(--muted); font-size:12px}
    @media (max-width: 900px){ .flow{grid-template-columns:1fr} }

    /* Do/Don't */
    .do-dont{display:grid; grid-template-columns:1fr 1fr; gap:14px}
    .do, .dont{border:1px solid var(--border); border-radius:12px; padding:14px; background:#f8fafc}
    .do h4, .dont h4{margin:6px 0 10px}
    .do h4{color: var(--good)}
    .dont h4{color: var(--bad)}
    @media (max-width: 800px){ .do-dont{grid-template-columns:1fr} }

    /* Footer */
    footer{padding: 40px 0 60px; color: var(--muted); text-align:center}

    /* Small utilities */
    .row{display:flex; gap:10px; flex-wrap:wrap}
    .mt-8{margin-top:8px} .mt-12{margin-top:12px} .mt-16{margin-top:16px} .mt-20{margin-top:20px}
    .mb-0{margin-bottom:0}
    .mono{font-family: ui-monospace, SFMono-Regular, Menlo, Monaco, Consolas, "Liberation Mono", "Courier New", monospace;}
    .divider{height:1px; background: var(--border); margin: 10px 0 14px}
    .right{margin-left:auto}
    .sr-only{position:absolute; width:1px; height:1px; padding:0; margin:-1px; overflow:hidden; clip:rect(0,0,0,0); white-space:nowrap; border:0}
  </style>
</head>
<body>
  <header class="hero">
    <div class="shell hero-inner">
      <div>
        <span class="brand-chip" aria-label="GatewayC GP resource">
          <!-- book icon -->
          <svg viewBox="0 0 24 24" fill="none" aria-hidden="true"><path d="M4 5.5A2.5 2.5 0 0 1 6.5 3H20v16.5a1.5 1.5 0 0 1-1.5 1.5H6.5A2.5 2.5 0 0 1 4 18.5V5.5Z" stroke="#0b3d91" stroke-width="1.5"/><path d="M4 6.5h13.5A1.5 1.5 0 0 1 19 8v11" stroke="#0b3d91" stroke-width="1.5"/></svg>
          GP Quick‑Glance • Urology
        </span>
        <h1>Urological Red Flags & First‑Line Actions</h1>
        <p class="subtitle">A light, modern reference for bladder, renal and testicular concerns—built from clinical conversation highlights.</p>
        <div class="cta-row">
          <a class="btn btn-primary" href="#red-flags">View Red Flags</a>
          <a class="btn btn-ghost" href="#algorithms">Jump to Algorithms</a>
        </div>
      </div>
      <aside class="hero-card" aria-label="At‑a‑glance stats">
        <div class="row">
          <span class="badge">Light Theme</span>
          <span class="badge">Clinic‑friendly</span>
          <span class="badge">Action‑oriented</span>
        </div>
        <div class="kpi" role="list" aria-label="Key statistics">
          <div class="tile" role="listitem"><div class="num">20–25%</div><div class="lbl">Visible haematuria → any urinary malignancy</div></div>
          <div class="tile" role="listitem"><div class="num">3–4%</div><div class="lbl">Non‑visible haematuria → malignancy</div></div>
          <div class="tile" role="listitem"><div class="num">98%+</div><div class="lbl">Testicular cancer cure rate (overall)</div></div>
        </div>
        <p class="mt-12 mb-0" style="color:var(--muted)">Use this sheet alongside NG12 thresholds. High‑risk features justify action even if below age cut‑offs.</p>
      </aside>
    </div>
  </header>

  <main class="shell grid">
    <!-- Main content -->
    <div>
      <section id="red-flags" class="card" aria-labelledby="rf-title">
        <h2 id="rf-title">1) Haematuria: act first, then explain</h2>
        <div class="row mt-8">
          <span class="pill red" title="Concerning feature">Red Flag</span>
          <span class="pill blue">Follow NG12</span>
        </div>
        <h3 class="mt-16">Urgent actions</h3>
        <ul class="list-tight">
          <li><strong>Visible haematuria</strong> (any sex) <strong>≥45 yrs</strong> → <span class="pill red">Suspected cancer referral</span> after infection excluded or if blood persists post‑UTI treatment.</li>
          <li><strong>Non‑visible haematuria</strong> <strong>≥60 yrs</strong> → <span class="pill red">Suspected cancer referral</span>.</li>
          <li><strong>Any age</strong> with <em>palpable bladder mass</em>, <em>constitutional symptoms</em> (weight loss, bone pain, new back pain in men ≥50, hypercalcaemia, AKI/obstruction signs) → <span class="pill red">Urgent evaluation</span>.</li>
        </ul>

        <div class="callout blue" role="note" aria-label="UTI vs cancer rule">
          <svg viewBox="0 0 24 24" fill="none" aria-hidden="true"><path d="M12 6v6l4 2" stroke="#1e3a8a" stroke-width="1.6" stroke-linecap="round"/></svg>
          <div>
            <strong>UTI vs cancer—simple rule</strong>
            <ul class="list-tight mt-8">
              <li><strong>UTI + blood</strong>: Treat UTI → <strong>repeat urinalysis at ~6 weeks</strong>. If blood persists, repeat once at <strong>2–4 weeks</strong>; if still present → <em>investigate/refer</em>.</li>
              <li><strong>Blood but no growth</strong> (sterile pyuria or clear haematuria): <strong>Don’t serially re‑test</strong>. <span class="pill red">Refer</span>.</li>
              <li><strong>Menstrual/uncertain source ("front, middle, back")</strong>: consider PV/speculum; repeat urine <strong>after menses</strong>. Proven urine blood with uncertain source → <strong>urology referral</strong>; add <strong>gynae</strong> if history suggests vaginal origin.</li>
            </ul>
          </div>
        </div>

        <h3>Primary care tests (when applicable)</h3>
        <ul class="list-tight">
          <li><strong>Urinalysis</strong> → <strong>MSU</strong> if infection suspected.</li>
          <li><strong>U&amp;Es</strong>.</li>
          <li><strong>Avoid X‑ray KUB</strong> (low yield, radiation).</li>
          <li><strong>Ultrasound KUB</strong>: not routine for cancer triage; <em>consider</em> in difficult, <strong>proven recurrent UTIs</strong> to check hydronephrosis/mass.</li>
        </ul>

        <div class="callout amber" role="note">
          <svg viewBox="0 0 24 24" fill="none" aria-hidden="true"><path d="M12 3l9 16H3L12 3Z" stroke="#7c2d12" stroke-width="1.6"/><circle cx="12" cy="14" r="1" fill="#7c2d12"/><path d="M12 9v3" stroke="#7c2d12" stroke-width="1.6"/></svg>
          <div>
            <strong>Below threshold but high‑risk?</strong> Smoking, occupational exposures, strong FHx, persistent visible bleeding, recurrent stones → justify <strong>urgent urology</strong> or <strong>Advice &amp; Guidance</strong> even if below NG12 age cut‑offs.
          </div>
        </div>
      </section>

      <section class="card" id="renal" aria-labelledby="renal-title">
        <h2 id="renal-title">2) Renal cancer: what to remember</h2>
        <ul class="list-tight">
          <li><strong>Mostly incidental</strong> on imaging nowadays.</li>
          <li>Classic triad (loin pain, mass, haematuria) is <strong>uncommon</strong>.</li>
          <li>Haematuria due to RCC is <strong>&lt;10%</strong> of RCC presentations.</li>
          <li>Watch for <strong>constitutional clues</strong>: weight loss, bone pain, hypercalcaemia; consider <strong>obstructive uropathy</strong> from lower tract disease too.</li>
        </ul>
      </section>

      <section class="card" id="recurrent-utis" aria-labelledby="ruti-title">
        <h2 id="ruti-title">3) Recurrent UTIs in women (post‑menopausal)</h2>
        <div class="row mt-8">
          <span class="pill.green pill green">Stepwise care</span>
        </div>
        <ol>
          <li><strong>Conservative</strong>: hydration, post‑coital voiding, avoid bladder irritants; D‑mannose/cranberry if patient wishes.</li>
          <li><strong>Topical vaginal oestrogen</strong> if atrophic symptoms.</li>
          <li><strong>Antibiotic strategies</strong>: patient‑initiated, prophylactic low‑dose, or cyclical (document cultures).</li>
          <li><strong>Still recurrent despite above (and infections proven)</strong> → order <strong>U&amp;Es</strong>; <strong>consider US KUB</strong> (hydronephrosis, bladder lesion, large residual); then <strong>urology referral</strong> (cystoscopy ± intravesical options; rule out CIS/TCC).</li>
        </ol>
        <p class="mt-12"><span class="badge">Remember</span> Any haematuria outside a proven/in‑treatment UTI → follow the haematuria referral rules.</p>
      </section>

      <section class="card" id="cysts" aria-labelledby="cyst-title">
        <h2 id="cyst-title">4) Renal cysts: decoding the report</h2>
        <div class="do-dont">
          <div class="do">
            <h4>Reassure (green)</h4>
            <ul class="list-tight">
              <li><strong>Simple renal cyst</strong> clearly stated → <span class="pill green">No cancer risk</span>; usually asymptomatic unless <strong>&gt;6–7 cm</strong>.</li>
              <li><strong>Small simple cysts (1–2 cm)</strong> → <em>no referral</em>.</li>
            </ul>
          </div>
          <div class="dont">
            <h4>Act / Refer (red)</h4>
            <ul class="list-tight">
              <li><strong>Complex cyst</strong> (septations/solid elements/“not simple”) → <strong>urology referral</strong> for CT &amp; <strong>Bosniak</strong> class.</li>
              <li><strong>Bosniak II</strong>: usually monitor (often discharge if stable 3–4 yrs).</li>
              <li><strong>Bosniak III–IV</strong>: ~<strong>50%+ malignant</strong> or malignant → consider <strong>partial nephrectomy</strong>.</li>
              <li><strong>Angiomyolipoma (AML)</strong> ≥4 cm → bleeding risk 5–10% (Wunderlich) → <strong>refer</strong> (embolisation/partial nephrectomy options).</li>
              <li><strong>Incidental solid renal mass</strong> → <strong>refer</strong>.</li>
            </ul>
          </div>
        </div>
      </section>

      <section class="card" id="testicular" aria-labelledby="testis-title">
        <h2 id="testis-title">5) Testicular lumps: don’t delay</h2>
        <div class="row mt-8">
          <span class="pill red">Expedite</span>
          <span class="pill blue">Seen within days where possible</span>
        </div>
        <ul class="list-tight">
          <li>Peak incidence: <strong>20s–30s</strong> (non‑seminoma ~20s; seminoma ~30s).</li>
          <li><strong>Hard, solid, intratesticular mass</strong> → <span class="pill red">Suspected cancer referral immediately</span> (don’t wait for community US).</li>
          <li><strong>Likely benign scrotal lumps</strong> (epididymal cyst, hydrocele, varicocele, hernia) → primary‑care US reasonable; refer if uncertain.</li>
        </ul>
        <h3>Risk factors to ask</h3>
        <ul class="list-tight">
          <li>Undescended testis/orchidopexy, subfertility, prior pelvic/inguinal radiotherapy, family history.</li>
        </ul>
        <p class="mt-12"><span class="badge">Metastatic pattern</span> Retroperitoneal nodes most common; lungs next.</p>
        <div class="callout green" role="note">
          <svg viewBox="0 0 24 24" fill="none" aria-hidden="true"><path d="M5 12l4 4L19 6" stroke="#064e3b" stroke-width="2" stroke-linecap="round"/></svg>
          <div>
            <strong>Patient education</strong>: Encourage monthly self‑exam; signpost to national charities (e.g., OddBalls) for how‑to guides and awareness.
          </div>
        </div>
      </section>

      <section class="card" id="special" aria-labelledby="special-title">
        <h2 id="special-title">6) Special cohort note</h2>
        <div class="callout amber" role="note">
          <svg viewBox="0 0 24 24" fill="none" aria-hidden="true"><circle cx="12" cy="12" r="9" stroke="#7c2d12" stroke-width="1.6"/><path d="M12 7v6" stroke="#7c2d12" stroke-width="1.6"/><circle cx="12" cy="16" r="1" fill="#7c2d12"/></svg>
          <div>
            <strong>Sickle cell disease/trait</strong>: very rare association with <em>renal medullary carcinoma</em>. No screening; maintain heightened vigilance for haematuria. Low threshold for urinalysis ± renal US if symptomatic.
          </div>
        </div>
      </section>

      <section class="card" id="algorithms" aria-labelledby="algo-title">
        <h2 id="algo-title">7) One‑minute algorithms</h2>
        <h3>Visible haematuria (≥45 yrs)</h3>
        <div class="flow" role="list">
          <div class="step" role="listitem"><div class="title">1) Dipstick ± MSU</div><div class="hint">If infection suspected.</div></div>
          <div class="step" role="listitem"><div class="title">2) If UTI present</div><div class="hint">Treat → repeat urinalysis ~6 wks (then +2–4 wks if needed).</div></div>
          <div class="step" role="listitem"><div class="title">3) Persisting blood or no growth</div><div class="hint"><span class="pill red">Suspected cancer referral</span>.</div></div>
        </div>

        <h3 class="mt-16">Non‑visible haematuria</h3>
        <div class="flow">
          <div class="step"><div class="title">≥60 yrs</div><div class="hint"><span class="pill red">Suspected cancer referral</span>.</div></div>
          <div class="step"><div class="title">Below threshold</div><div class="hint">Use judgement; high‑risk → urgent urology/A&amp;G.</div></div>
          <div class="step"><div class="title">Investigations</div><div class="hint">Urinalysis/MSU; U&amp;Es; avoid X‑ray KUB.</div></div>
        </div>

        <h3 class="mt-16">Testicular lump</h3>
        <div class="flow">
          <div class="step"><div class="title">1) Examine</div><div class="hint">Solid intratesticular vs benign scrotal.</div></div>
          <div class="step"><div class="title">2) If solid testicular mass</div><div class="hint"><span class="pill red">Immediate suspected cancer referral</span>.</div></div>
          <div class="step"><div class="title">3) If benign features</div><div class="hint">Primary‑care US; refer if atypical/uncertain.</div></div>
        </div>

        <h3 class="mt-16">Recurrent proven UTIs (post‑menopausal)</h3>
        <div class="flow">
          <div class="step"><div class="title">Conservative</div><div class="hint">Hydration, behaviours, D‑mannose/cranberry.</div></div>
          <div class="step"><div class="title">Hormonal/ABx</div><div class="hint">Topical oestrogen; prophylactic/cyclical/PRN ABx.</div></div>
          <div class="step"><div class="title">Escalate</div><div class="hint">U&amp;Es ± US KUB → urology referral.</div></div>
        </div>
      </section>

      <section class="card" id="dosdonts" aria-labelledby="dd-title">
        <h2 id="dd-title">8) Do / Don’t</h2>
        <div class="do-dont">
          <div class="do">
            <h4>Do</h4>
            <ul class="list-tight">
              <li>Document <strong>infection status</strong> before/with referral decisions.</li>
              <li><strong>Safety‑net</strong> with time‑bound rechecks (e.g., repeat urine ~6 wks).</li>
              <li>Use <strong>Advice &amp; Guidance</strong> for sub‑threshold but high‑risk cases.</li>
            </ul>
          </div>
          <div class="dont">
            <h4>Don’t</h4>
            <ul class="list-tight">
              <li>Serially repeat MSUs for <strong>non‑visible haematuria with no growth</strong> in eligible ages—<strong>refer</strong>.</li>
              <li>Order <strong>X‑ray KUB</strong> for cancer work‑up or stones screening.</li>
              <li>Delay <strong>testicular mass</strong> referrals while awaiting community US if cancer suspected.</li>
            </ul>
          </div>
        </div>
      </section>

      <section class="card" id="phrases" aria-labelledby="phrases-title">
        <h2 id="phrases-title">9) Phrases for your notes</h2>
        <div class="row mt-8">
          <span class="pill blue">Copy‑ready</span>
          <span class="pill green">Clinic use</span>
        </div>
        <ul>
          <li class="mono">Visible haematuria, MSU no growth. No UTI. Meets NG12 → 2WW urology.</li>
          <li class="mono">UTI with haematuria treated. Plan: repeat urinalysis in 6 weeks; safety‑net given.</li>
          <li class="mono">Complex renal cyst on US ("not simple") → urology referral for CT/Bosniak.</li>
          <li class="mono">Hard, intratesticular mass on exam → urgent suspected testicular cancer referral; safety‑net provided.</li>
        </ul>
      </section>

      <section class="card" id="patient" aria-labelledby="patient-title">
        <h2 id="patient-title">10) Patient messages (safety‑net lines)</h2>
        <ul class="list-tight">
          <li>“If you <strong>see blood again</strong>, pain worsens, develop <strong>fever/rigors</strong>, or feel <strong>unwell</strong>, contact us urgently or 111/ED.”</li>
          <li>“Any <strong>new testicular lump</strong> or rapid change → same‑day contact.”</li>
        </ul>
      </section>

    </div>

    <!-- Sticky TOC -->
    <nav class="toc" aria-label="On‑page navigation">
      <h3>Quick Nav</h3>
      <a href="#red-flags">Haematuria: Red Flags</a>
      <a href="#renal">Renal Cancer Essentials</a>
      <a href="#recurrent-utis">Recurrent UTIs</a>
      <a href="#cysts">Renal Cysts</a>
      <a href="#testicular">Testicular Lumps</a>
      <a href="#special">Special Cohorts</a>
      <a href="#algorithms">Algorithms</a>
      <a href="#dosdonts">Do / Don’t</a>
      <a href="#phrases">Note Phrases</a>
      <a href="#patient">Patient Safety‑net</a>
    </nav>
  </main>

  <footer class="shell">
    <div class="divider" aria-hidden="true"></div>
    <p>Designed for bright clinic environments (no dark UI). Use alongside local pathways and NG12.</p>
  </footer>

  <script>
    // Smooth scrolling for in‑page anchors
    document.querySelectorAll('a[href^="#"]').forEach(a=>{
      a.addEventListener('click', e=>{
        const id = a.getAttribute('href').slice(1);
        const el = document.getElementById(id);
        if(el){ e.preventDefault(); el.scrollIntoView({behavior:'smooth', block:'start'}); }
      })
    })
  </script>
</body>
</html>